Clinical Trials

The purpose of this study is to examine a pilot intervention that will target social communication, cognition, and mood regulation. This multi-faceted, behavioral intervention can be individualized to improve independence and QoL in adults with Autism Spectrum Disorder (ASD) across the lifespan.

The purpose of this study is to confirm a correlation between metal ion dyshomeostasis (low Zn levels, abnormal Zn/Cu ratio, or low Selenium levels) in a North American population and the diagnosis of ASD using gold standard diagnostic instruments.

The purpose of this study is to determine whether a group recreation intervention for six to eight year old children with autism, who have deficits in gross motor skills is feasible and acceptable. Additionally the study will explore whether a group recreation intervention can improve gross motor skills, social skills, physical activity, and reduce parent stress.

Autism Spectrum Disorders (ASDs) are lifelong neurodevelopmental conditions with mostly unknown etiology that have a huge impact on affected individuals and their families, and are a major public health concern.  Significant gaps exist in the knowledge of ASD frequency and its possible rising trend.  Detailed characterization of ASD cases ASD subtypes is sparse, and potential risk factors (etiologies) are still unknown.  We will study certain risk factors like perinatal risk factors and family history (parents, siblings) of psychiatric disorders.  Knowledge about adult outcomes of ASD cases identified in childhood is almost non-existent.  ASD-associated medical costs are high, yet information to ...

The purpose of this study is to screen mothers of young children with Autism Spectrum Disorders for metabolic problems, and find if it can be treated with a vitamin/mineral supplement with a different form of folic acid and more B12. These mothers will also be compared to the same number of mothers of normal children for the same metabolic markers.

The purpose of this project is to systematically engage clinicians/scientists, patients and their families as stakeholders critical to the future of gene editing governance, so as to ensure that their values and priorities are identified, understood and to the extent possible aligned.

The ultimate objective is to provide an integrated pathway to a governance structure for the future of prenatal human gene editing in the United States.